8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001564590-21-058797
Material agreement · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading cccc-8k_20211124.htm…